The heart‐liver metabolic axis: defective communication exacerbates disease
Authors:
Open Access
- 12 March 2014
- journal article
- editorial
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 6 (4) , 436-438
Abstract
The heart has been recognized as an endocrine organ for over 30 years (de Bold, 2011); however, little is known about how the heart communicates with other organs in the body, and even less is known about this process in the diseased heart. In this issue of EMBO Molecular Medicine , Magida and Leinwand (2014) introduce the concept that a primary genetic defect in the heart results in aberrant hepatic lipid metabolism, which consequently exacerbates hypertrophic cardiomyopathy (HCM). This study provides evidence in support of the hypothesis that crosstalk occurs between the heart and liver, and that this becomes disrupted in the diseased state.Keywords
This publication has 16 references indexed in Scilit:
- A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid useNature, 2013
- G protein-coupled receptors for energy metabolites as new therapeutic targetsNature Reviews Drug Discovery, 2012
- A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13Cell, 2012
- Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?European Heart Journal, 2012
- Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesJournal of Clinical Investigation, 2012
- Thirty years of research on atrial natriuretic factor: historical background and emerging conceptsCanadian Journal of Physiology and Pharmacology, 2011
- Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Estrogen Regulation of Adiposity and Fuel PartitioningJournal of Biological Chemistry, 2005
- Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophyJACC, 2003
- Animal models of hypertrophic cardiomyopathyCurrent Opinion in Cardiology, 2000